APX-3330 | m-entrepreneurship.com

Product Name :
APX-3330

Search keywords :
APE1

drugId :
null

Target Vo:
DNA-(apurinic or apyrimidinic site) lyase

Target Vo Short Name :
DNA-(apurinic or apyrimidinic site) lyase

Moa_Name:
DNA-(apurinic or apyrimidinic site) lyase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Eisai Co Ltd

Active Company_Name :
Apexian Pharmaceuticals Inc

Active Indication_Name:
Diabetic macular oedema

In Active Indication_Name:
Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
p38 (YP7068) Mouse mAb In stock
BMP2 Antibody Technical Information
Adipose Triglyceride Lipase Antibody: Adipose Triglyceride Lipase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 55 kDa, targeting to Adipose Triglyceride Lipase. It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts